In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ReNeuron licenses stem cell patents from Amrad

Executive Summary

Australian pharmaceutical R&D company Amrad (infectious and neurological diseases; allergy and inflammation) licensed ReNeuron Holdings PLC (treatments for neurological disorders) exclusive worldwide rights to its patent for c-Myc and related genes. ReNeuron will use c-Myc to immortalize human neural cells in order to derive stable human cell lines suitable for clinical trials.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies